Search research articles
Contact Us
Filters
Showing results (11-20 of 47) with videos related to
Page
of 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 2, 2015
Synergistic Leukemia Eradication by Combined Treatment with Retinoic Acid and HIF Inhibition by EZN-2208 (PEG-SN38) in Preclinical Models of PML-RARα and PLZF-RARα-Driven Leukemia
Nadia Coltella, Roberta Valsecchi, Manfredi Ponente, et al.
Genes & Cancer
|
March 15, 2013
Compound In Vivo Inactivation of Pml and p53 Uncovers a Functional Interaction in Angiosarcoma Suppression
Antonella Papa, Carlos Cordon-Cardo, Rosa Bernardi, et al.
Genome Medicine
|
December 3, 2014
A HIF-1 network reveals characteristics of epithelial-mesenchymal transition in acute promyelocytic leukemia
Stefano Percio, Nadia Coltella, Sara Grisanti, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 24, 2006
The promyelocytic leukemia protein functions as a negative regulator of IFN-gamma signaling
Youn-Hee Choi, Rosa Bernardi, Pier Paolo Pandolfi, et al.
Heliyon
|
September 12, 2024
PML is a constitutive component of chromatin domains enriched in repetitive elements and duplicated gene clusters in cancer cells
Cristina Fracassi, Matilde Simoni, Martina Uggè, et al.
Blood
|
January 1, 2005
The promyelocytic leukemia protein PML regulates c-Jun function in response to DNA damage
Paolo Salomoni, Rosa Bernardi, Stephan Bergmann, et al.
Stem Cell Reports
|
June 18, 2014
Bone marrow endosteal mesenchymal progenitors depend on HIF factors for maintenance and regulation of hematopoiesis
Jlenia Guarnerio, Nadia Coltella, Ugo Ala, et al.
Nature
|
July 12, 2005
Role of nucleophosmin in embryonic development and tumorigenesis
Silvia Grisendi, Rosa Bernardi, Marco Rossi, et al.
Open Biology
|
May 14, 2020
EZN-2208 treatment suppresses chronic lymphocytic leukaemia by interfering with environmental protection and increases response to fludarabine
Roberta Valsecchi, Nadia Coltella, Daniela Magliulo, et al.
EMBO Molecular Medicine
|
March 10, 2011
Pml represses tumour progression through inhibition of mTOR
Rosa Bernardi, Antonella Papa, Ainara Egia, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 47) with videos related to
Sort By:
Page
of 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 2, 2015
Synergistic Leukemia Eradication by Combined Treatment with Retinoic Acid and HIF Inhibition by EZN-2208 (PEG-SN38) in Preclinical Models of PML-RARα and PLZF-RARα-Driven Leukemia
Nadia Coltella, Roberta Valsecchi, Manfredi Ponente, et al.
Genes & Cancer
|
March 15, 2013
Compound In Vivo Inactivation of Pml and p53 Uncovers a Functional Interaction in Angiosarcoma Suppression
Antonella Papa, Carlos Cordon-Cardo, Rosa Bernardi, et al.
Genome Medicine
|
December 3, 2014
A HIF-1 network reveals characteristics of epithelial-mesenchymal transition in acute promyelocytic leukemia
Stefano Percio, Nadia Coltella, Sara Grisanti, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 24, 2006
The promyelocytic leukemia protein functions as a negative regulator of IFN-gamma signaling
Youn-Hee Choi, Rosa Bernardi, Pier Paolo Pandolfi, et al.
Heliyon
|
September 12, 2024
PML is a constitutive component of chromatin domains enriched in repetitive elements and duplicated gene clusters in cancer cells
Cristina Fracassi, Matilde Simoni, Martina Uggè, et al.
Blood
|
January 1, 2005
The promyelocytic leukemia protein PML regulates c-Jun function in response to DNA damage
Paolo Salomoni, Rosa Bernardi, Stephan Bergmann, et al.
Stem Cell Reports
|
June 18, 2014
Bone marrow endosteal mesenchymal progenitors depend on HIF factors for maintenance and regulation of hematopoiesis
Jlenia Guarnerio, Nadia Coltella, Ugo Ala, et al.
Nature
|
July 12, 2005
Role of nucleophosmin in embryonic development and tumorigenesis
Silvia Grisendi, Rosa Bernardi, Marco Rossi, et al.
Open Biology
|
May 14, 2020
EZN-2208 treatment suppresses chronic lymphocytic leukaemia by interfering with environmental protection and increases response to fludarabine
Roberta Valsecchi, Nadia Coltella, Daniela Magliulo, et al.
EMBO Molecular Medicine
|
March 10, 2011
Pml represses tumour progression through inhibition of mTOR
Rosa Bernardi, Antonella Papa, Ainara Egia, et al.
Page
of 5